Pay in 4 interest-free payments of $7.48 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
10mg/vial, 99%+ purity, HPLC verified
From thymosin alpha-1 and its capacity to rebalance T-cell populations, to KPV and its targeted anti-inflammatory action through NF-kB inhibition, to experimental peptides like P140/Lupuzor that have reached Phase III clinical trials specifically for lupus, the landscape of peptide-based immune modulation is expanding rapidly
The 3mL format is useful for precise small-volume laboratory preparation and peptide research procedures where reduced waste and controlled handling are important
Their solutions meet high standards, ensuring accurate peptide reconstitution and safe injections every time
Notice Provided as a reference material for scientific investigation only
When adverse effects occurred, they were typically mild and transient, with the most common being mild to moderate headaches (similar frequency to placebo groups), minor injection site reactions (redness, slight swelling), and gastrointestinal effects at higher oral doses (nausea, diarrhea)
.png?w=1536&max-h=2752&fit=crop&auto=format)
